Trials / Sponsors / Adnexus, A Bristol-Myers Squibb R&D Company
Adnexus, A Bristol-Myers Squibb R&D Company
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme Glioblastoma Multiforme | Phase 1 | 2008-10-01 |
| Unknown | CT-322 in Treating Patients With Recurrent Glioblastoma Multiforme and Combination Therapy With Irinotecan Brain and Central Nervous System Tumors, Recurrent Glioblastoma Multiforme | Phase 2 | 2007-10-01 |
| Completed | CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma Cancer | Phase 1 | 2006-08-01 |